Article

Wwraltechwire.com on 2023-01-07 04:54

Alzheimer's drug from Biogen, partner receives FDA approval

U.S. health officials on Friday approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential ...

Related news

MBiogen talks up approval plans for controversial Alzheimer's drug as it nears FDA decision marketwatch.com
Japan , Switzerland , Canada , Brazil , Australia
BBiogen Partner Eisai Files for Accelerated Approval of Alzheimer's Drug2 min read barrons.com
Japan
Biogen receives FDA approval for breakthrough ALS treatment: ‘Pivotal moment in ALS research’bradenton.com
Cambridge
BFDA Will Weigh Full Approval for Alzheimer's Drug. Why It Matters for Biogen Stock. 3 min read barrons.com
Japan
FDA calls for investigation of Biogen Alzheimer's drug approval bizjournals.com
Biogen shares soar as FDA reviewers support Alzheimer's drug Sydney Morning Herald
Wall Street , Massachusetts , Cambridge
Breakthrough Alzheimer's drug earns accelerated FDA approval New York Post
BA Third Expert Quits FDA Panel Over Approval of Biogen Alzheimer's Drug 2 min barrons.com
Biogen, Eisai to push for fast FDA approval for second Alzheimer's drug bizjournals.com
MBiogen says it will pursue FDA approval of early Alzheimer's drug marketwatch.com
MFDA chief tells reporters “transfer on” when pushing for approval of Biogen Alzheimer’s mvtelegraph.com
Wall Street , Massachusetts , Cambridge
GTx receives FDA approval bizjournals.com
Emergent receives FDA approval thedailyrecord.com
BBiogen Stock Jumps on FDA Approval barrons.com
Wall Street , Mount Sinai , Unmet
Moderna's Covid-19 vaccine receives full FDA approval CNN
United States , Israel , Japan , Canada , Hong Kong
Lilly to seek FDA approval for potential Alzheimer's drug - Thu, 24 Jun 2021 PST The Spokesman-Review
Japan , Indianapolis
Biogen cutting cost of Alzheimer's drug Arkansas Online
Japan , Cambridge